Shi Zhikang,Zhang Shengli,Zhao Minli,et al.Repair of urethral defects in rabbits using adipose stem cells and vascular endothelial cells co-cultured with acellular matrix materials[J].Journal of Clinical Pediatric Surgery,2020,19(04):310-316.[doi:10.3969/j.issn.1671-6353.2020.04.006]
脂肪干细胞和血管内皮细胞共培养复合脱细胞基质材料修复兔尿道缺损的实验研究
- Title:
- Repair of urethral defects in rabbits using adipose stem cells and vascular endothelial cells co-cultured with acellular matrix materials
- Keywords:
- Tissue Engineering; Adipose Derived Stem Cells; Endothelial Cells; Coculture Techniques; acellular matrix; Urethra/IN
- 分类号:
- R695;R318
- 摘要:
- 目的 本实验拟探讨应用脂肪干细胞（adipose-derived stem cells，ADSCs）和血管内皮细胞（vascular endothelial cells，VEC）体外共培养，联合脱细胞基质材料构建人工尿道修复兔尿道缺损的效果。方法 体外分离培养、扩增获得兔脂肪干细胞和血管内皮细胞，分别将ADSCs、VEC以及二者共培养细胞群与脱细胞基质结合。将48只雄性成年新西兰兔阴茎腹侧尿道制作成缺损长度为2.0 cm的动物模型，然后利用随机数字表法分为4组。无细胞对照组：单纯应用异种脱细胞基质修复组。ADSCs组：脂肪干细胞复合异种脱细胞基质手术修复组；VEC组：血管内皮细胞复合脱细胞基质手术修复组；ADSCs与VEC共培养组：ADSCs与VEC共培养后复合异种脱细胞基质手术修复组。分别于术后第1周、2周、4周、8周取各组实验动物的重建尿道组织，进行组织学及免疫组化观察分析。术后第8周观察各组动物排尿情况，记录有无尿瘘和尿道狭窄。结果 体外培养扩增的ADSCs呈梭形生长，VEC形态多样，呈铺路石样；两者共培养7 d时部分细胞仍保持原有的梭形，另外一部分细胞呈多角形，巢样分布，14 d时观察可见细胞间存在许多相互连接的突触，并且部分细胞可融合成团块状。术后4周、8周分别对各组兔子尿道行免疫组织化学染色分析，可见ADSCs与VEC共培养组上皮血管内皮细胞因子（VEGF）、平滑肌肌动蛋白（a-SMA）明显多于无细胞对照组、ADSCs组、VEC组。术后8周无细胞对照组并发症发生率为75%（9/12），ADSCs组为41.7%（5/12），VEC组为33.3%（4/12），ADSCs与VEC共培养组为16.7%（2/12），四组间差异有统计学意义（χ2=8.914，P<0.05）。进一步两两比较发现，无细胞对照组与ADSCs与VEC共培养组相比差异有统计学意义（P<0.0083）。无细胞对照组与ADSCs组、无细胞对照组与VEC组、ADSCs组与VEC组、ADSCs组与ADSCs和VEC共培养组及VEC组与ADSCs和VEC共培养组比较，差异均无统计学意义（P>0.0083）。结论 ADSCs和VEC经体外共培养后可作为种子细胞应用于组织工程尿道的构建和尿道缺损的修复。VEC可诱导ADSCs向上皮细胞方向转变，并增加尿道组织血管的发生。
- Abstract:
- Objective To co-culture adipose derived stem cells (ADSCs) and vascular endothelial cells (VEC) in vitro and add acellular matrix materials for reconstructing artificial urinary urethral defect.Methods Isolation,culture and amplification of rabbit ADSCs and VEC were performed.Respectively ADSCs,VEC and both were seeded to acellular matrix.A total of 48 male adult New Zealand rabbits were randomly divided into 4 groups with a length of urethral defect at 2.0 cm.Ccell-free control group was a simple application of acellular matrix; ADSCs:acellular matrix composite surgical repair; VEC:VEC acellular matrix surgical repair; ADSCs & VEC co-culturing group:ADSCs plus VEC co-cultured with acellular matrix composite.Urethral tissues were examined by histology and immunohistochemistry at 1,2,4 and 8 weeks.Urethral fistula and stricture were recorded at 8 weeks.Results ADSCs were fusiform shapes in vitro and cellular morphology of VEC was diverse and slabstone.Both were co-cultured for 7 days,some cells still retained original spindle and other cells were polygonal and nest-like.At 14 days,there were a lot of interconnected synapses and some of them fused into a mass.Urethra of each rabbit was observed at 4 and 8 weeks post-operation.The number of capillary and smooth muscle was higher in ADSCs & VEC co-culturing than that in Cell-free control/ADSCs/VEC group.Vascular endothelial growth factor (VEGF) and smooth muscle actin (SMA) were positive in ADSCs vs. VEC.After 8 weeks,the complications occurred in 9/12 cases (75%) in Cell-free,5/12 (41.7%) in ADSCs,4/12 (33.3%) in VEC and 2/12 (16.7%) in ADSCs & VEC.And the differences were statistically significant (χ2=8.914,P<0.05).Conclusion Cell-free and ADSCs & VEC,the difference was statistically significant (P<0.0083); comparing Cell-free & ADSCs,Cell-free & VEC,ADSCs & VEC,ADSCs & ADSCs & VEC and VEC & ADSCs & VEC,the differences were not statistically significant (P>0.0083).Conclusion After in vitro co-culturing,ADSCs and VEC may be used as seeds for tissue engineering urethra and repairing urethral defect.And VEC transforms ADSCs into epithelial cells and increases the occurrence of blood vessels in urethra.
参考文献/References:
1 Atala A,Danilevskiy M,Lyundup A,et al.The potential role of tissue-engineered urethral substitution:clinical and preclinical studies[J].J Tissue Eng Regen Med,2017,11(1):3-19.DOI:10.1002/term.2112.
2 宋鲁杰,徐月敏,傅强,等.口腔内黏膜尿道成形治疗前尿道狭窄10年经验总结[J].中华泌尿外科杂志,2011,32(11):728-731.DOI:10.3760/cma.j.issn.1000-6702.2011.11.003. Song LJ,Xu YM,Fu Q,et al.Oral mucosal grafts urethroplasty for the treatment of anterior urethral strictures:a ten-year clinical experience[J].Chin J Urol,2011,32(11):728-731.DOI:10.3760/cma.j.issn.1000-6702.2011.11.003.
3 李虹,罗德毅.尿道修复重建进展[J].现代泌尿外科杂志,2012,17(1):6-9.DOI:10.3969/j.issn.1009-8291.2012.01.004. Li H,Luo DY.Recent advances in urethral reconstruction[J].J Mod Urol,2012,17(1):6-9.DOI:10.3969/j.issn.1009-8291.2012.01.004.
4 杨嗣星,申复进,王玲珑.组织工程化尿道研究现状与前景[J].中华泌尿外科杂志,2006,27(12):861-863.DOI:10.3760/j:issn:1000-6702.2006.12.020. Yang SX,Shen FJ,Wang LL,et al.Current status and future prospects of tissue engineered urethra[J].J Chin J Urol,2006,27(12):861-863.DOI:10.3760/j:issn:1000-6702.2006.12.020.
5 Feil G,Daum L,Amend B,et al.From tissue engineering to regenerative medicine in urology-the potential and the pitfalls[J].Adv Drug Deliv Rev,2011,63(4-5):375-378.DOI:10.1016/j.addr.2010.12.003.
6 Wood D,Southgate J.Current status of tissue engineering in urology[J].Curr Opin Urol,2008,18(6):564-569.DOI:10.1097/MOU.0b013e32830f9402.
7 Gimble JM,Katz AJ,Bunnell BA.Adipose-derived stem cells for regenerative medicine[J].Circ Res,2007,100(9):1249-1260.DOI:10.1161/01.RES.0000265074.83288.09.
8 徐月敏,乔勇,吴登龙,等.游离黏膜组织重建尿道治疗复杂性尿道狭窄的临床研究[J].中华泌尿外科杂志,2005,26(7):485-487.DOI:10.3760/j:issn:1000-6702.2005.07.016. Xu YM,Qiao Y,Wu DL,et al.Clinical study of one-stage urethroplasty using free mucosa for the treatment of complex urethral stricture,[J].J Chin J Urol,2005,26(7):485-487.DOI:10.3760/j:issn:1000-6702.2005.07.016.
9 Caplan AI.Tissue engineering designs for the future:new logics,old molecules[J].Tissue Eng,2000,6(1):1-8.DOI:10.1089/107632700320838.
10 Newman KD,McBurney MW.Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells[J].Biomaterials,2004,25(26):5763-5771.DOI:10.1016/j.biomaterials.2004.01.027.
11 Mantovani F,Trinchieri A,Castelnuovo C,et al.Reconstructive urethroplasty using porcine acellular matrix[J].Eur Urol,2003,44(5):600-602.
12 韩平,杨志明,智伟,等.膀胱平滑肌细胞与小肠黏膜下层体外复合培养的实验研究[J].中国修复重建外科杂志,2007,21(12):1366-1370. Han P,Yang ZM,Zhi W,et al.Experimental studies on canine bladder smooth muscle cells cultured on acellular small intestinal submucosa in vitro[J].J Chin J Repair Recon Sur,2007,21(12):1366-1370.
13 Sievert KD,Bakircioglu ME,Nunes L,et al.Homologous acellular matrix graft for urethral reconstruction in the rabbit:histological and functional evaluation[J].J Urol,2000,163(6):1958-1965.
14 Fliniaux I,Viallet JP,Dhouailly D,et al.Transformation of amnion epithelium into skin and hair follicles[J].Differentiation,2004,72(9-10):558-565.DOI:10.1111/j.1432-0436.2004.07209009.x.
15 Atala A.Tissue engineering for the replacement of organ function in the genitourinary system[J].Am J Transplant,2004,4(Suppl 6):58-73.
相似文献/References:
[1]吴少峰,何蓉,孙杰,等.组织工程补片在重度尿道下裂分期手术中的应用[J].临床小儿外科杂志,2018,17(08):577.
Wu Shaofeng,He Rong,Sun Jie,et al.Twostaged urethroplasty with tissueengineered graft for proximal hypospadias with severe chordee.[J].Journal of Clinical Pediatric Surgery,2018,17(04):577.
[2]於明明,陈方.组织工程技术在儿童下尿路重建修复中的若干问题[J].临床小儿外科杂志,2020,19(04):285.[doi:10.3969/j.issn.1671-6353.2020.04.001]
Yu Mingming,Chen Fang.Research progress of tissue engineering in pediatric urology[J].Journal of Clinical Pediatric Surgery,2020,19(04):285.[doi:10.3969/j.issn.1671-6353.2020.04.001]
[3]曾甜,李新宁,黄晶晶,等.同种异体脱细胞真皮修补术治疗巨型脐膨出的疗效分析[J].临床小儿外科杂志,2020,19(04):306.[doi:10.3969/j.issn.1671-6353.2020.04.005]
Zeng Tian,Li Xinning,Huang Jingjing,et al.Efficacy of allogeneic acellular dermal mantrix in repairing giant omphalocele[J].Journal of Clinical Pediatric Surgery,2020,19(04):306.[doi:10.3969/j.issn.1671-6353.2020.04.005]
[4]陈峰,沈立.CorMatrix在心脏外科中的应用[J].临床小儿外科杂志,2020,19(04):321.[doi:10.3969/j.issn.1671-6353.2020.04.008]
Chen Feng,Shen Li.Application of CorMatrix in cardiac surgery[J].Journal of Clinical Pediatric Surgery,2020,19(04):321.[doi:10.3969/j.issn.1671-6353.2020.04.008]
备注/Memo
收稿日期:2018-05-04。
基金项目:河南省医学科技攻关计划项目（编号：201602055）；河南省医学科技攻关计划项目（编号：201203005）；河南省高等学校重点科研项目计划（编号：18A320046）
通讯作者:范应中,Email:fanyingzhong2@163.com